Obinutuzumab for Named Patient Import

Obinutuzumab for Patients in India

Obinutuzumab is one of the latest FDA approved drugs. The clinical research outcomes suggest its significance in the treatment of chronic lymphocytic leukemia (CLL) in adults. It is also indicated in the treatment of Follicular Lymphoma. Obinutuzumab in India has its scope of usage too. Roche is the innovator of this product. Gazyva is its registered brand name for commercial purposes. Gazyva in India is becoming relevant with several Hematologists recommending it.

Gazyva or Obinutuzumab price in India may be understood based on the international prices. It is prescribed based on the patient’s assessment for eligibility. It is not accessible from the Indian Onco Pharmacies because it is yet to be registered. This doesn’t limit Indian patients from sourcing Gazyva. Named Patient licensing is the best way to import such medications.

Obinutuzumab in India? We can assist

If you are prescribed for using Gazyva in India, you can consider our assistance to expedite the process. Our team of experts will help you connect with trusted sources in the Europe. We only recommend verified sources. We have the reputation and experience of supporting Indian patients with due procedures. You can be confident of working with suppliers who are duly authorized for Obinutuzumab India supplies.

Email at nhs@noelbiotech.com or call us on + 91 9677010046 / + 91 9929277766.